
US Employers to Reduce Weight-Loss Drug Coverage by 2027 Amid Rising Healthcare Costs
A growing number of U.S. employers are expected to discontinue coverage for weight-loss drugs by 2027 due to escalating healthcare expenses. This shift reflects a trend where companies are re-evaluating benefits in response to increasing financial pressures.




